$3.000
-0.134 (-4.46%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Armata Pharmaceuticals, Inc. (ARMP) Moving Averages Convergence Divergence (MACD) indicator is -0.22, suggesting ARMP is Strong sell.
Armata Pharmaceuticals, Inc. (ARMP) 20-Day simple moving average is 3.24, while Armata Pharmaceuticals, Inc. (ARMP) share price is $—, making it Sell.
Armata Pharmaceuticals, Inc. (ARMP) 60-Day simple moving average is 4.15, while Armata Pharmaceuticals, Inc. (ARMP) share price is $—, making it Sell.
Technical Analysis for ARMP
AI Technical ARMPAs of 2026-11-03, the technical board for Armata Pharmaceuticals, Inc. (ARMP) reads strong sell: 0 indicators are flashing buy, 9 are indicating sell, and 4 are neutral. Price at $3.00 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 41.204, MACD stands at -0.22 (Sell), Stochastic %K stands at 26.596, Stochastic %D stands at 26.252 and CCI stands at -80.928.
ARMP trades below the 60-day SMA (4.15) and below the 200-day SMA (6.95). Immediate resistance sits at Classic R1 3.79, then R2 4.34. Support sits at Classic S1 2.75, then S2 2.26.
Armata Pharmaceuticals, Inc. (ARMP) Support & Resistance Level
Armata Pharmaceuticals, Inc. (ARMP) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 41.204 |
| STOCHk_14_3_3 | 26.596 |
| STOCHd_14_3_3 | 26.252 |
| CCI_20 | -80.928 |
| AO_5_34 | -0.368 |
| MOM_10 | -0.450 |
| MACD_12_26_9 | -0.220 |
Armata Pharmaceuticals, Inc. (ARMP) Relative Strength Index (RSI_14) is 41.204, creating a Neutral signal.
Armata Pharmaceuticals, Inc. (ARMP) Stochastic %K is 26.596, creating a Neutral signal.
Armata Pharmaceuticals, Inc. (ARMP) Stochastic %D is 26.252, creating a Neutral signal.
Armata Pharmaceuticals, Inc. (ARMP) CCI_20 is -80.928, creating a Neutral signal.
Armata Pharmaceuticals, Inc. (ARMP) Awesome Oscillator (AO) is -0.368, creating a Sell signal.
Armata Pharmaceuticals, Inc. (ARMP) Momentum (MOM) is -0.450, creating a Sell signal.
Armata Pharmaceuticals, Inc. (ARMP) Moving Average Convergence Divergence (MACD) is -0.220, creating a Sell signal.
Armata Pharmaceuticals, Inc. (ARMP) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.072 | Sell |
| MA_10 | 3.248 | Sell |
| MA_20 | 3.243 | Sell |
| MA_60 | 4.153 | Sell |
| MA_200 | 6.951 | Sell |
| MA_250 | 6.836 | Sell |
Armata Pharmaceuticals, Inc. (ARMP) 5-Day simple moving average is 3.072, while Armata Pharmaceuticals, Inc. (ARMP) share price is $, making it a Sell.
Armata Pharmaceuticals, Inc. (ARMP) 10-Day simple moving average is 3.248, while Armata Pharmaceuticals, Inc. (ARMP) share price is $, making it a Sell.
Armata Pharmaceuticals, Inc. (ARMP) 20-Day simple moving average is 3.243, while Armata Pharmaceuticals, Inc. (ARMP) share price is $, making it a Sell.
Armata Pharmaceuticals, Inc. (ARMP) 60-Day simple moving average is 4.153, while Armata Pharmaceuticals, Inc. (ARMP) share price is $, making it a Sell.
Armata Pharmaceuticals, Inc. (ARMP) 200-Day simple moving average is 6.951, while Armata Pharmaceuticals, Inc. (ARMP) share price is $, making it a Sell.
Armata Pharmaceuticals, Inc. (ARMP) 250-Day simple moving average is 6.836, while Armata Pharmaceuticals, Inc. (ARMP) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.